Eastman Chemical (EMN) Research & Development (2009 - 2026)

Eastman Chemical (EMN) has reported Research & Development for 18 consecutive years, with $65.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 2.99% year-over-year to $65.0 million; the trailing twelve-month figure through Jun 2026 stood at $246.0 million (down 7.17% YoY), and the FY2025 full-year result was $255.0 million, up 2.0% from the prior year.
• Research & Development rose to $65.0 million in Q2 2026 per EMN's latest filing, from $60.0 million in the prior quarter.
• Across five years, Research & Development topped out at $68.0 million in Q3 2022 and bottomed at $57.0 million in Q4 2023.
• Historically, Research & Development has averaged $62.9 million across 5 years, with a median of $63.5 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Research & Development increased 15.79% in 2024, then decreased 12.12% in 2025.
• Over 5 years, Research & Development stood at $64.0 million in 2022, then fell by 10.94% to $57.0 million in 2023, then climbed by 15.79% to $66.0 million in 2024, then fell by 12.12% to $58.0 million in 2025, then grew by 12.07% to $65.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $65.0 million, $60.0 million, and $58.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.